Table 2.

Chemosensitivity of different histologic subtypes of soft tissue sarcoma and treatment options

DTIC dacarbazine, DTX docetaxel, DXR doxorubicin, GEM gemcitabine, IFM ifosfamide, PTX paclitaxel, VAC vincristine, actinomycin D, and cyclophosphamide, VAI vincristine, actinomycin D, and ifosfamide, VAIA vincristine, doxorubicin, ifosfamide, and actinomycin D, VDC/IE vincristine, doxorubicin, cyclophosphamide, and ifosfamide and etoposide, VIE vincristine, ifosfamide, and etoposide

^aNot approved for the treatment of STS in Japan